Top compounds associated with response to RIPPLY1


Feature Type Standardized
Nominal ANOVA
mRNA ML083 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Bortezomib gCSI pan-cancer AAC -0.21 0.0005
mRNA SR1001 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CHIR-99021 CTRPv2 pan-cancer AAC 0.095 0.004
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.22 0.004
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.006
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.008
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.087 0.008
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.12 0.009
Download CSV